Home › Rectal Cancer › NCT02107105

Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer

Prospective Evaluation of Quality of Life and Utilities Following Surgical Treatment of Rectal Cancer

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Patient has histologically proven adenocarcinoma of the rectum (stage I - IV) that is planned to be treated by surgical resection performed with curative intent, or who has already received surgical treatment
* Patient must sign an approved informed consent document and have the literary and physical ability to complete the questionnaire in English

Exclusion Criteria:

* Patient has been treated with pelvic radiation therapy for a diagnosis other than rectal cancer
* Patient has a concurrent cancer diagnosis at the time of consent
* Patient has recurrent disease

About the study

This study evaluates quality of life and utilities following surgical treatment of stage I-IV rectal cancer. This study may help researches learn more about quality of life in patients who have or have had rectal cancer.

What is being tested

• Quality-of-Life Assessment (other)
• Questionnaire Administration (other)

Sponsor: M.D. Anderson Cancer Center · Participants: 430 · Started: May 16, 2014

Contact the study team

• George Chang · Phone: 713-792-6940

Official record on ClinicalTrials.gov — NCT02107105

Locations in the U.S.

Conditions

• Rectal Cancer

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.